Epidemiology Flashcards
Which of the following refers to the incidence rate of dementia in a
catchment area?
A. Number of patients with dementia during a specifi ed time interval
B. Number of newly diagnosed patients with dementia
C. Ratio of the number of newly diagnosed patients with dementia during a specifi ed time
interval to the total population in the same area
D. Ratio of the number of patients with dementia at a given time to the total population
in the same area
E. Number of newly diagnosed patients with dementia who are still surviving at the time
of the survey
C. The incidence of a disease is defi ned as the number of ‘new’ cases diagnosed in a
specifi ed time interval for a specifi ed size of population at risk. The midinterval population usually
determines this population size. For example while calculating the incidence of a disease in 1 year,
the comparison is made against the midyear population.
Incidence in 2008 =
Number of newly diagnosed cases in 2008
Mid 2008 population in an area
Incidence is a rate ratio, that is it is measured against time. It is not a mere number and it is
usually expressed per 100 000 persons in a population, per year. The essential criterion is that the
measure should indicate all new occurrences of a disease within the period of observation in an
area, irrespective of whether the newly diagnosed patients are cured or dead within the period
of observation itself. For an accurate measurement of incidence, two cross-sectional surveys
must be carried out in the same population; one must be at the beginning of a defi ned period
and the other at the end of the same period.
In a National Comorbidity Survey carried out in the US, the proportion of
the sampled individuals who ever manifested criteria of panic disorder in
their lifetime was determined. This can be best described as which of the
following?
A. Incidence
B. Point prevalence
C. Lifetime prevalence
D. Lifetime morbid risk
E. Period prevalence
C. Lifetime prevalence is the proportion of individuals in the population who have ever
manifested a disorder, who are alive on a given day. This is ascertained by surveying a population
cross-sectionally and fi nding out if they ever satisfi ed the criteria for a disorder in the past or at
the present time. As one can observe, although this method is commonly used in epidemiological
surveys, it is prone to recall bias. Lifetime morbid risk refers to risk of contracting a disease for
each individual in a birth cohort if they live long enough to reach the average life expectancy of
the population. This must be clearly differentiated from prevalence estimates. Prevalence is largely
a population measure, while lifetime morbid risk is more close to an individual’s chances of being
diagnosed with an illness
Using case records, the number of newly diagnosed cases of psychosis in
south-east London was determined for a period of 33 years, between 1965
and 1997. To calculate incidence rate, which of the following is the most
suitable denominator?
A. Total south-east London population in the year 1965 minus number of cases
B. Total south-east London population in the year 1997
C. Census of south-east London population aged more than 16 in the year 1981
D. Census of south-east London population aged more than 16 in the year 1965
E. Census of south-east London population aged more than 16 in the year 1997
C. Incidence is a ratio between the number of newly diagnosed cases within a specifi ed time
period in a population and the total number of people living in the area (total population). To be
accurate, such comparisons must exclude those who are not at risk, though this is generally not
done for non-infectious, non-epidemic diseases such as psychiatric illnesses. It is essential that
the denominator and numerator are not mutually exclusive, that is the diseased group must be a
part of the studied population. Hence, when measuring the incidence of psychosis, the population
above the age of 16 is the relevant denominator. The year 1981 is the midinterval period
between 1965 and 1997
Which of the following equations gives the relationship between prevalence
and incidence?
A. Prevalence = duration of disease × incidence rate
B. Incidence rate = duration of disease × prevalence
C. Prevalence = mortality rate × incidence rate
D. Incidence rate = mortality rate × prevalence
E. Prevalence = mortality rate × incidence × duration of disease
A. Prevalence is defi ned as the number of ‘existing’ cases in a specifi ed population for a
period of observation (either cross-sectional observation, called point prevalence, or longitudinal
observation for a specifi ed time, called period prevalence). The existing cases include all new
cases and all cases diagnosed before the observation but still suffering from the disease, but
existing cases excludes those who have been previously diagnosed but are now cured or dead.
For illnesses that are signifi cantly chronic (e.g. schizophrenia), prevalence will be higher compared
to those illnesses that are acute and short lived (e.g. infl uenza), even if the incidence rates are
comparable. Hence the simple expression
prevalence = incidence × duration of illness
explains the relationship between incidence and prevalence.
A major cause of mortality in schizophrenia is cardiovascular problems.
If a new class of antipsychotics with favourable metabolic profi le that
reduces cardiac risk is introduced, which of the following could happen?
A. Increase in incidence and prevalence of schizophrenia
B. Increase in prevalence of schizophrenia, but reduced incidence
C. Increased prevalence but unaffected incidence
D. Reduction in both incidence and prevalence
E. Both incidence and prevalence will remain unaffected
C. Certain factors can infl uence incidence and prevalence differently. For example if a new
vaccine is developed to prevent an illness, both incidence and prevalence may come down. If a
cure is developed for schizophrenia, incidence may not be affected but prevalence could drop.
Similarly, if interventions are introduced to reduce mortality in chronic schizophrenia, then
prevalence may paradoxically increase due to longevity of patients. This may not affect incidence
rates directly.
Which of the following expresses an incidence rate measured for a subgroup of a population? A. Crude mortality rate B. Lifetime prevalence rate C. Standardized mortality rate D. Specifi c mortality rate E. Survival rate
D. Mortality rates are a special type of incidence rates where ‘death’ is the defi ned ‘case’
of interest. Crude mortality rate is the ratio between number of deaths due to all cause in a
population and total population size. Cause-specifi c mortality rate, for example alcohol-specifi c
mortality, refers to the ratio between the number of deaths due to alcohol in a population and
total population size. A standardized rate is a rate applicable to a hypothetical population with
an adjusted variable, for example age. As population samples are heterogeneous, crude rates
from one population may not be comparable to another population. For example suicide rates in
inner London may not be comparable to rates in rural Yorkshire, as the working-age population
may be higher in London, spuriously increasing suicide rates. Hence, standardized hypothetical
populations are used on which observed rates from a population are applied and adjusted
values are derived. These standardized values are easily comparable, but they are not subgroup
incidence rates.
Which of the following correctly expresses proportional mortality rate
due to anorexia nervosa?
A. Number of anorexia-related deaths in a year/ total midyear population
B. Number of anorexia-related deaths in a year/ total number of all cause deaths
C. Number of anorexia-related deaths in a year/ total number of new cases diagnosed
with anorexia in the same year
D. Number of anorexia-related deaths in a year/ 1-year prevalence of anorexia
E. Number of all cause deaths in a year/ number of anorexia-related deaths in the
same year
B. Proportionate mortality rate is a measure of the contribution of a disease to societal
mortality burden. It is given by the ratio between deaths due to a specifi c cause and total number
of deaths in a population. Case fatality rate is the ratio between the number of deaths due to a
specifi c disease and number of persons affected by the disease in a population. It is a measure of
the fatal severity of the disease studied. For example 15 patients out of 100 with anorexia will die
due to its complications. Choice A refers to cause-specifi c mortality rate while choice D refers to
case fatality rate.
Which of the following is a major advantage in using standardized
morality rate compared to crude mortality rate?
A. Comparisons between populations is easier with the standardized rate.
B. True value of the number of deaths in a population is given by a standardized rate.
C. Standardized rates can be expressed in meaningful units while crude rates do not
have a specifi c unit for expression.
D. Standardized rates provide an idea about cause of deaths in a population.
E. The accuracy of measurement is increased by using standardized rates.
A. The true value of the number of deaths in a population is obtained using crude mortality
fi gures. Both standardized and crude rates are expressed in the same units of incidence.
Standardized rates are not the same as specifi c rates. Disease-specifi c rates can give an idea
about cause of death in a population. Standardized rates increase comparability, not the accuracy
of measurement of mortality in a population.
There are 65 suicides in a population of 1300 patients with schizophrenia.
The rate 65/1300 refers to which one of the following?
A. Proportional mortality rate
B. Cause-specifi c mortality rate
C. Case fatality rate
D. Standardized mortality rate
E. Crude mortality rate
B. This is an example of cause-specifi c (suicide is the cause) mortality rate in a population
(number of schizophrenia patients). If the comparison is between the number of patients died
with a diagnosis of schizophrenia and total number of patients at a given time interval, then
this becomes case fatality rate for schizophrenia. If deaths due to suicides in a population with
schizophrenia are compared with all-cause deaths in the same population then this will be
proportionate mortality due to suicide. A ‘case’ of suicide cannot be identifi ed alive, though
patients who attempted suicides can be identifi ed. So describing a ‘case’ fatality rate for suicide
is meaningless. Nevertheless, method-specifi c case fatality can be derived for various modes of
suicide attempts.
Patients with undiagnosed subsyndromal hypomania have clinical
characteristics closely resembling which one of the following diagnoses?
A. Bipolar type 1
B. Dysthymia with depression
C. Depression with stimulant use
D. Bipolar type 2
E. Major depressive disorder
D. In large epidemiological studies, a consistent 1.5% prevalence is quoted for bipolar
disorders. It is unclear whether there is an over-inclusion of depressive disorders and underdiagnosis
of bipolar type 2 disorder in these surveys. Hypomania, being positively appraised
by patients themselves, is often missed in structured, non-clinician interviews. Angst et al., in a
20-year-long prospective study, observed that patients with depression and clinically undiagnosed
subsyndromal hypomania have similar risk factors, course, and outcome compared to bipolar
disorder type 2.
In major epidemiological studies, the mean time lag between onset and
clinical treatment for major depressive disorder is determined to be around
A. 3 months
B. 3 weeks
C. 3 years
D. 13 years
E. 3 days
C. According to NESARC (National Epidemiological Survey of Alcoholism and Related
Conditions) the mean age of onset of depression is 30 years, the mean number of episodes in
patients with lifetime major depressive disorder is fi ve, and the mean age of treatment onset for
depression is 33.5 years. This lag of around 3 years is noted in other community samples that
studied treatment seeking for depression. It is currently unclear if untreated depression, as noted
in population surveys, affects clinical outcome in long-term follow-up.
Considering the epidemiology of major depressive disorder, which of
the following is incorrect with respect to seeking treatment?
A. Nearly half of men with depression do not get treated.
B. Women seek treatment more often than men.
C. Treatment is sought earlier in developed countries.
D. Less than 20% of depressive episodes do not come to clinical attention.
E. Earlier onset is associated with poorer treatment-seeking behaviour.
D. Nearly 40% of depressive episodes do not come to clinical attention even in developed
nations (NESARC study). The World Mental Health Survey initiative organized by the WHO
revealed that older generational cohorts of depressed people, men, those with earlier age of
depression onset, and those who are living in developing compared to developed countries are
poor seekers of treatment for depression. The situation is even worse for anxiety and substanceuse
disorders. An encouraging fi nding was that those with severe illness sought treatment more
often than those with milder illnesses
Major depressive disorder often coexists with personality disorders.
Which of the following groups of personality disorders is most commonly
associated with depression?
A. Paranoid, schizotypal, and schizoid
B. Histrionic, borderline, and antisocial
C. Dependent and anxious avoidant
D. Sadistic and narcissistic
E. Obsessive compulsive and passive aggressive
C. The most common comorbidities with depression in epidemiological surveys are
alcohol use (>40%) and anxiety (>40%). It is noted that cluster C personality disorders, with the
exception of obsessive compulsive personality disorder, show strong associations with lifetime
major depression in large-scale community surveys. In Question 13, choice A refers to cluster
A personality, choice B to cluster B, and choice C to two of the three cluster C personality
disorders. Choice D includes disorders described in DSM IV but not clustered in any of the three
groups.
Major depressive disorder often coexists with personality disorders. What
is the proportion of patients with major depression and lifetime
comorbidity of personality disorders in community samples?
A. 10%
B. 60%
C. 75%
D. 3%
E. 30%
E. It is important to note that the prevalence of personality disorders in those who attend
psychiatric services or primary-care services are higher than community prevalence rates. The
rate of personality disorders is recorded to be very high in institutions such as prisons and
psychiatric hospitals providing long-term services. The prevalence of any personality disorder
in community samples is estimated to be around 13% in the UK. The comorbid association of
diagnosable personality disorder and depression was explored in NESARC study, which revealed
30% of depressed patients in the community have a comorbid personality disorder
To estimate the number of homeless mentally ill patients, an initial survey
was carried out in a defi ned area of central London and identifi ed patients
were registered. Six months later, another random sampling was carried
out and using the identifi ed proportion of previously registered homeless
mentally ill, reliable population values were deducted. This method of
epidemiological survey is best described as
A. Capture–recapture study
B. Cohort study
C. Cross-sectional survey
D. Audit
E. Comorbidity survey
A. This is called capture–recapture technique. It is useful in estimating the size of a
population that cannot be directly estimated as only a fraction is observable when using sampling
techniques. Initially, a random sample from the population of interest is drawn (e.g. mentally
ill homeless population). After registering these patients they are allowed to mix with the
population (using a registration tag, they can be identifi ed again). When complete mixture with
the total population has occurred, a second random sample is drawn. From the prevalence of the
registered patients in the second sample, the size of the total population may be calculated. This
technique is being used in animal research to provide estimates of census of animals.
Who fi rst coined the term comorbidity? A. Folstein B. Feinstein C. Einstein D. Bradford Hill E. Gauss
B. The term comorbidity refers to the existence of two different diagnoses at the same
time in an individual. In psychiatric epidemiology, comorbidity is a rule rather than exception.
This high degree of comorbidity is partly due to the overlapping nature of diagnostic entities
in psychiatry. Comorbidity in epidemiological research throws light onto possible aetiological
underpinnings and meaningful outcome variables. Feinstein coined the term comorbidity. The
various types of comorbidity are:
1. Episode (concurrent) comorbidity
2. Lifetime comorbidity
3. Coincidental comorbidity (co-occurrence by chance)
4. Associative comorbidity (risk factor or causal link).
Which of the following is the best estimate of the incidence of schizophrenia if a rigorous systematic review of various epidemiological studies to date is carried out? A. 15 per 100 000 B. 1 per 100 C. 4 per 1000 D. 7 per 1000 E. 5 per 100 000
A. The rigorous, systematic review mentioned in the question was carried out by McGrath
and colleagues. Prior to this, in 1986, the WHO published results from the International Pilot
Study on Schizophrenia from seven countries; incidence of ICD 9 schizophrenia was estimated
to be around 16 to 42 per 100 000 in a year. When schizophrenia was narrowly defi ned, this rate
dropped to 7 to 14 per 100 000. McGrath et al. showed a fi vefold difference in the incidence
rates of schizophrenia across various sites in their systematic review and meta-analysis of various
epidemiological studies on schizophrenia. According to this work, it is concluded that the median
global incidence rate of schizophrenia is 15 per 100 000; but this global rate is not as meaningful
as site-specifi c rates due to the degree of variation demonstrated. This view is endorsed by the
AESOP study, which showed signifi cant variation in incidence of schizophrenia among three major
cities in England.
The male to female risk ratio for developing schizophrenia is calculated to be which of the following values? A. 1 : 1 B. 1.4 : 1 C. 3 : 1 D. 1 : 2 E. 4 : 1
B. The male to female difference in incidence of schizophrenia is estimated to be around
1.4: 1, with more males being diagnosed with the disease. The male excess persists even when
factors such as age range and diagnostic criteria are taken into account; but interestingly this
difference is not borne out when considering prevalence rates, suggesting that different factors
exist in predisposing and perpetuating the illness. It may be related to males having higher
mortality rates than females with schizophrenia or increased predominance of females in
late-onset schizophrenia.
The risk ratio for developing schizophrenia in migrants compared to a native population is A. 1 to 2.6 B. 1.6 to 1 C. 4.6 to 1 D. 6 to 1 E. 1 to 1
C. Being born in an urban area increases the risk of schizophrenia twofold compared
to individuals born in a rural area. Living in a city is also noted to increase incidence of
schizophrenia. The incidence of schizophrenia is three to fi ve times more common in migrants
than a native population (median 4.6); this difference reduces to 1.8 when considering prevalence
rates. Fluctuations in schizophrenia incidence have been reported over many decades. This may
be related to changing structure of the population. Irrespective of broad or narrow defi nitions,
the incidence of schizophrenia has defi nitely increased in certain urban areas over the last
40 years.
The probability of developing a disorder anytime throughout the life course of a birth cohort is called A. Lifetime prevalence B. Lifetime morbid risk C. Life expectancy D. Period prevalence E. Cumulative incidence
B. Lifetime prevalence needs to be distinguished from lifetime morbid risk (LMR). LMR
is the probability of a person developing the disorder during entire period of their life (often
a specifi ed period, defi ned by the life expectancy of the population studied). LMR includes the
entire lifetime of a birth cohort, both past and future, and includes those deceased at the time of
the survey.
Which of the following could be estimated using the summation of
age-specifi c incidence rate of schizophrenia throughout the average
life expectancy of a population?
A. Age-specifi c prevalence rate of schizophrenia
B. Lifetime morbid risk of schizophrenia
C. Lifetime prevalence of schizophrenia
D. Cumulative incidence of schizophrenia
E. Period prevalence estimate of schizophrenia
B. For low-incidence disorders such as schizophrenia, summation of age-specifi c incidence rates
gives approximate lifetime morbid risk values. The lifetime morbid risk for schizophrenia is 7.2/1000.
The male: female ratio for prevalence of schizophrenia is estimated to be A. 1 : 1 B. 2 : 1 C. 3 : 1 D. 1 : 2 E. 2 : 3
A. The median prevalence of schizophrenia was 4.6/1000 for point prevalence, 3.3/1000
for period prevalence, and 4.0/1000 for lifetime prevalence. There were no signifi cant differences
observed between males and females, or between urban, rural, and mixed sites with respect
to the prevalence rates of schizophrenia. Migrants and homeless people had higher rates of
schizophrenia and developing countries had lower prevalence rates.
The lifetime morbidity ratio associated with schizophrenia is estimated to be A. 15 per 100 000 B. 1 per 100 C. 4 per 1000 D. 7 per 1000 E. 5 per 100 000
D. The lifetime morbidity risk estimated for schizophrenia is around 7 per 1000 people in
the population
The population attributable fraction for seasonal birth in the incidence of schizophrenia is estimated to be around A. 30% B. 50% C. 2% D. 10% E. 6%
D. Population attributable fraction refers to the proportion of a disease in the whole
population that the group exposed to specifi c risk factors represents. It is calculated by fi nding
out the difference between incidence rates in the total population and the exposed population,
and expressing this difference as a proportion of the total population’s incidence rate. It is
different from simple attributable risk, which expresses the difference in incidence rates between
the exposed and non-exposed groups. Winter/ spring birth increases the risk of schizophrenia to
a small extent (RR 1.11), but as the prevalence of birth itself is common in winter/ spring, 10.5%
of all schizophrenia incidences can be attributed to the seasonal birth. The winter/ spring excess
is positively associated with latitude.
The incidence rate of an illness varies widely across different countries.
The prevalence measures, calculated at the same time, do not follow the
same pattern of variation but are uneven. Which of the following could
explain this disparity?
A. Different scales were used for measuring new and old cases
B. Recall bias explains the high incidence rates
C. Respondent bias explains the prevalence rates
D. The risk factors for causation and prognosis are different
E. The disease is a fatal condition
D. If the measurement methodologies differ between how a case is ascertained for
incidence and prevalence, then such differences will be uniformly present across various sites.
Recall bias will not infl uence incidences measured using case notes or case registers. On the
other hand, lifetime prevalence rates are susceptible to recall bias. Respondent bias, if present,
must again operate uniformly and should affect various areas consistently, provided the same
methods are used. A fatal disease must reduce prevalence rates uniformly. The most likely
explanation is that the factors predisposing or precipitating the onset are different from the
factors that serve to maintain the illness chronicity.
The frequency of adults reporting lifetime presence of mental health
problems in Europe is estimated to be around
A. 1 in 4
B. 1 in 10
C. 1 in 2
D. 1 in 25
E. 1 in 100
A. ESEMeD was the fi rst major multicentre European psychiatric epidemiological study; it was
not conducted in the UK. It used both Composite International Diagnostic Interview (CIDI) version
3.0 (WHO) and Structured Clinical Interview for DSM Disorders (SCID) based clinical diagnosis
(DSM IV criteria). ESEMeD is a part of the World Mental Health Survey Initiative of the WHO. The
results showed that 1 in 4 adults in Europe had a lifetime presence of a mental disorder and 1 in
10 had a mental disorder in the last year; 14.7% had a lifetime history of mood disorder (major
depression only,13%), while 14% had anxiety (specifi c phobia only, 8%), and 5.2% had a lifetime
alcohol-use disorder. The highest rate of mental disorder was in the age group 18–24
Considering pathways of care in mental health, which of the following is
not a major fi lter for help seeking?
A. Self-recognition of emotional diffi culties
B. Diagnostic ability of a general practitioner
C. Acceptance rate at secondary care
D. Occupational health initiatives at a place of employment
E. In-patient admission facilities at local psychiatric services
D. Also called the fi lter model, the ‘pathways of care’ model was developed by Goldberg
and Huxley to account for how mental illness interacts with the health-care system. Five levels
of mental illness occurrence were described: the community, the primary-care attendees, the
correctly diagnosed primary-care attendees (in whom the mental illness has been recognized),
the level of the psychiatrist, and that at the level of psychiatric in-patient care. Four fi lters explain
the decreasing incidence when going from the general population to in-patient psychiatric care:
1. At the level of the patient himself or herself (recognition)
2. At the level of the general practitioner (recognition, decision to treat, decision to refer)
3. At the out-patient level of the mental health-care system
4. At the in-patient admission level.
Occupational health resources are not major fi lters in this model.
In epidemiological surveys across life span, the term persistence refers
to which of the following?
A. Number of patients with lifetime prevalence who have 12 months prevalence
B. Number of patients with 12 months prevalence who will develop chronic problems
if followed up
C. Number of patients with lifetime prevalence who spent more than 1/3 of life with
the disease
D. Number of patients with lifetime prevalence who spent more than 1/2 of life with
the disease
E. Number of patients with lifetime prevalence who are seeking health-care input
A. Persistence is defi ned as the total number of patients with lifetime prevalence of a
disorder who also satisfy a defi ned period prevalence, say 12 months, criteria at the time of
survey. It is a measure of illness chronicity, response to treatment, and burden.